BeyondSpring Pharmaceuticals Inc. is a pharmaceutical company based in New York, New York, specializing in the development and commercialization of innovative cancer therapies. Situated in the heart of Manhattan at 28 Liberty Street, the company focuses on advancing treatments that address unmet medical needs in oncology. Its operations are rooted in research and clinical development aimed at delivering novel solutions to patients and healthcare providers.
The company engages in a range of activities from early-stage drug discovery to clinical trials, working to bring promising compounds through the regulatory process. BeyondSpring Pharmaceuticals Inc. collaborates with medical experts and research institutions to enhance the effectiveness and safety profiles of its products. Its approach integrates scientific research with practical application, striving to contribute meaningfully to cancer care advancements.
As a participant in the pharmaceutical industry, BeyondSpring Pharmaceuticals Inc. operates within a complex regulatory environment that demands rigorous testing and compliance. The company’s location in New York provides access to a rich network of healthcare professionals, academic institutions, and biotechnology partners. This strategic positioning supports its ongoing efforts to innovate and respond to the evolving challenges in cancer treatment.
BeyondSpring Pharmaceuticals Inc. can be contacted by phone at 646-305-6387 for inquiries related to its research and product pipeline. While primarily focused on oncology, the company’s broader goal is to improve patient outcomes through targeted therapies. Its presence in New York underscores its role as an active contributor to the pharmaceutical landscape within the region and beyond.


































